Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease
Authors:
L. Smardova a;
A. Engert b;
H. Haverkamp c;
JM Raemakers d;
JW Baars e;
B. Pfistner c;
V. Diehl c;
A. Josting b
| Affiliations: | a Internal Department of Hematooncology, University Hospital Brno, Brno, Czech Republic |
| b First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany | |
| c German Hodgkin's Lymphoma Study Group, Trial Center, Cologne, Germany | |
| d Department of Hematology, University Medical Centre, Nijmegen, The Netherlands | |
| e Department of Medical Oncology, Netherland Cancer Institute, Amsterdam, The Netherlands |
DOI:
10.1080/10428190500064276
Publication Frequency:
12 issues per year
Number of References: 20
Formats available:
HTML
(English)
:
PDF
(English)
Cited By
This article is cited by 2 other articles. You must have access to this article in order to view its citations.


Download Citation
